TRELLUS HEALTH LS -0006 (85Q) - Total Liabilities
Based on the latest financial reports, TRELLUS HEALTH LS -0006 (85Q) has total liabilities worth €513.00K EUR (≈ $599.75K USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
TRELLUS HEALTH LS -0006 - Total Liabilities Trend (2021–2024)
This chart illustrates how TRELLUS HEALTH LS -0006's total liabilities have evolved over time, based on quarterly financial data. See TRELLUS HEALTH LS -0006 working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
TRELLUS HEALTH LS -0006 Competitors by Total Liabilities
The table below lists competitors of TRELLUS HEALTH LS -0006 ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
HPI AG
MU:CEW3
|
Germany | €38.52 Million |
|
Investor Centre Ltd
AU:ICU
|
Australia | AU$3.25 Million |
|
UMT United Mobility Technology AG
XETRA:UMDK
|
Germany | €4.28 Million |
|
Gangotri Textiles Limited
NSE:GANGOTRI
|
India | Rs2.52 Billion |
|
Kiromic Biopharma Inc
NASDAQ:KRBP
|
USA | $21.13 Million |
|
Oriole Resources PLC
LSE:ORR
|
UK | GBX3.54 Million |
|
Europa Oil & Gas Holdings
LSE:EOG
|
UK | GBX6.00 Million |
Liability Composition Analysis (2021–2024)
This chart breaks down TRELLUS HEALTH LS -0006's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 85Q stock market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.63 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.06 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.06 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how TRELLUS HEALTH LS -0006's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for TRELLUS HEALTH LS -0006 (2021–2024)
The table below shows the annual total liabilities of TRELLUS HEALTH LS -0006 from 2021 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | €371.00K ≈ $433.74K |
-52.80% |
| 2023-12-31 | €786.00K ≈ $918.92K |
-4.38% |
| 2022-12-31 | €822.00K ≈ $961.00K |
-45.96% |
| 2021-12-31 | €1.52 Million ≈ $1.78 Million |
-- |
About TRELLUS HEALTH LS -0006
Trellus Health plc provides digital chronic condition management solutions for employers and health plans. The company offers GRITT resilience-based methodology; and TrellusElevate, a HIPAA-compliant technology platform for remote telemedicine care. Its platform provides support for managing inflammatory bowel disease, including Crohn's Disease and ulcerative colitis. The company was incorporated… Read more